Puma Biotechnology

$11.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.36 (+3.23%) Today
-$0.01 (-0.09%) As of 4:19 PM EST after-hours

Why Robinhood?

You can buy or sell PBYI and other stocks, options, and ETFs commission-free!

About PBYI

Puma Biotechnology Inc Common Stock, also called Puma Biotechnology, is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA. The listed name for PBYI is Puma Biotechnology Inc Common Stock.

CEO
Alan H. Auerbach
Employees
269
Headquarters
Los Angeles, California
Founded
2010
Market Cap
458.06M
Price-Earnings Ratio
Dividend Yield
Average Volume
622.42K
High Today
$12.01
Low Today
$11.16
Open Price
$11.25
Volume
750.87K
52 Week High
$15.00
52 Week Low
$5.50

Collections

PBYI Earnings

-$1.00
-$0.55
-$0.10
$0.35
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 18, After Hours

You May Also Like